Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Gross Margin 2010-2025 | PRPH

Current and historical gross margin for ProPhase Labs (PRPH) over the last 10 years. The current gross profit margin for ProPhase Labs as of March 31, 2025 is %.
  
ProPhase Labs Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.01B $0.00B 40.00%
2024-12-31 $0.01B $0.00B 16.67%
2024-09-30 $0.00B $0.00B -400.00%
2024-06-30 $0.01B $0.00B -33.33%
2024-03-31 $0.02B $0.00B 23.53%
2023-12-31 $0.03B $0.02B 44.12%
2023-09-30 $0.06B $0.03B 48.39%
2023-06-30 $0.08B $0.04B 51.28%
2023-03-31 $0.09B $0.05B 56.38%
2022-12-31 $0.12B $0.07B 57.72%
2022-09-30 $0.15B $0.09B 58.22%
2022-06-30 $0.13B $0.08B 58.78%
2022-03-31 $0.11B $0.06B 55.86%
2021-12-31 $0.08B $0.04B 53.85%
2021-09-30 $0.04B $0.02B 50.00%
2021-06-30 $0.03B $0.02B 48.48%
2021-03-31 $0.03B $0.01B 46.43%
2020-12-31 $0.02B $0.00B 26.67%
2020-09-30 $0.01B $0.00B 23.08%
2020-06-30 $0.01B $0.00B 25.00%
2020-03-31 $0.01B $0.00B 20.00%
2019-12-31 $0.01B $0.00B 30.00%
2019-09-30 $0.01B $0.00B 27.27%
2019-06-30 $0.01B $0.00B 30.00%
2019-03-31 $0.01B $0.00B 36.36%
2018-12-31 $0.01B $0.00B 33.33%
2018-09-30 $0.01B $0.00B 33.33%
2018-06-30 $0.01B $0.00B 23.08%
2018-03-31 $0.01B $0.00B 16.67%
2017-12-31 $0.01B $0.00B 10.00%
2017-09-30 $0.01B 0 0.00%
2017-06-30 $0.01B 0 0.00%
2017-03-31 $0.00B 0 0.00%
2016-12-31 $0.00B 0 0.00%
2016-09-30 $-0.01B $-0.01B 100.00%
2016-06-30 $0.00B $0.00B 100.00%
2016-03-31 $0.00B $0.00B 100.00%
2015-12-31 $0.00B $0.00B 50.00%
2015-09-30 $0.02B $0.01B 66.67%
2015-06-30 $0.02B $0.02B 68.18%
2015-03-31 $0.02B $0.02B 68.18%
2014-12-31 $0.02B $0.02B 68.18%
2014-09-30 $0.02B $0.02B 69.57%
2014-06-30 $0.02B $0.02B 66.67%
2014-03-31 $0.02B $0.02B 66.67%
2013-12-31 $0.03B $0.02B 65.38%
2013-09-30 $0.03B $0.02B 64.00%
2013-06-30 $0.02B $0.02B 62.50%
2013-03-31 $0.02B $0.02B 62.50%
2012-12-31 $0.02B $0.01B 63.64%
2012-09-30 $0.02B $0.01B 65.00%
2012-06-30 $0.02B $0.01B 70.00%
2012-03-31 $0.02B $0.01B 70.00%
2011-12-31 $0.02B $0.01B 70.59%
2011-09-30 $0.02B $0.01B 68.75%
2011-06-30 $0.02B $0.01B 68.75%
2011-03-31 $0.02B $0.01B 66.67%
2010-12-31 $0.01B $0.01B 64.29%
2010-09-30 $0.02B $0.01B 58.82%
2010-06-30 $0.02B $0.01B 58.82%
2010-03-31 $0.02B $0.01B 55.56%
2009-12-31 $0.02B $0.01B 55.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.582B 28.73
Zoetis (ZTS) United States $68.989B 25.74
Takeda Pharmaceutical (TAK) Japan $46.711B 9.29
Daiichi Sankyo, - (DSNKY) Japan $41.733B 21.39
BeOne Medicines - (ONC) Cayman Islands $27.433B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.614B 0.00
Summit Therapeutics (SMMT) United States $18.567B 0.00
Merck (MKKGY) Germany $17.150B 12.57
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.330B 11.79
Neurocrine Biosciences (NBIX) United States $13.208B 45.24
Orion OYJ (ORINY) Finland $11.038B 29.85
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.635B 46.69
Corcept Therapeutics (CORT) United States $7.623B 61.97
Madrigal Pharmaceuticals (MDGL) United States $7.004B 0.00
Grifols, S.A (GRFS) Spain $6.697B 0.00
Ionis Pharmaceuticals (IONS) United States $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.068B 15.41
Soleno Therapeutics (SLNO) United States $4.110B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.988B 19.65
Catalyst Pharmaceuticals (CPRX) United States $2.660B 9.32
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.611B 14.12
NewAmsterdam Pharma (NAMS) Netherlands $2.418B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.927B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.833B 0.00
Ocular Therapeutix (OCUL) United States $1.757B 0.00
ARS Pharmaceuticals (SPRY) United States $1.737B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.445B 0.00
ProKidney (PROK) United States $1.329B 0.00
Guardian Pharmacy Services (GRDN) United States $1.291B 0.00
Harrow (HROW) United States $1.281B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.189B 23.78
Enliven Therapeutics (ELVN) United States $1.102B 0.00
Ardelyx (ARDX) United States $1.074B 0.00
Collegium Pharmaceutical (COLL) United States $1.045B 5.64
Akebia Therapeutics (AKBA) United States $1.032B 0.00
Verve Therapeutics (VERV) United States $0.983B 0.00
Dyne Therapeutics (DYN) United States $0.982B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.930B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
KalVista Pharmaceuticals (KALV) United States $0.722B 0.00
Zevra Therapeutics (ZVRA) United States $0.685B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.685B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.614B 13.36
Bioventus (BVS) United States $0.573B 14.52
Theravance Biopharma (TBPH) United States $0.565B 0.00
Elite Pharmaceuticals (ELTP) United States $0.554B 0.00
Organogenesis (ORGO) United States $0.545B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.484B 10.10
Tourmaline Bio (TRML) United States $0.462B 0.00
Savara (SVRA) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.398B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.12
Altimmune (ALT) United States $0.336B 0.00
Heron Therapeutics (HRTX) United States $0.333B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
AleAnna (ANNA) United States $0.310B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 26.47
Aldeyra Therapeutics (ALDX) United States $0.279B 0.00
OmniAb (OABI) United States $0.248B 0.00
Nanobiotix S.A (NBTX) France $0.244B 0.00
Esperion Therapeutics (ESPR) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
China SXT Pharmaceuticals (SXTC) China $0.203B 0.00
4D Molecular Therapeutics (FDMT) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Liminatus Pharma (LIMN) United States $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Galectin Therapeutics (GALT) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.151B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.122B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.112B 18.41
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Vivani Medical (VANI) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Achieve Life Sciences (ACHV) Canada $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Jupiter Neurosciences (JUNS) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
PMV Pharmaceuticals (PMVP) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 33.33
Mural Oncology (MURA) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Vivos Therapeutics (VVOS) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
BioVie (BIVI) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.05
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00